S&P 500
(0.80%) 5 277.51 points

Dow Jones
(1.51%) 38 686 points

Nasdaq
(-0.01%) 16 735 points

Oil
(-0.94%) $77.18

Gas
(0.35%) $2.58

Gold
(-0.79%) $2 347.70

Silver
(-3.10%) $30.56

Platinum
(0.63%) $1 044.50

USD/EUR
(-0.17%) $0.921

USD/NOK
(-0.49%) $10.49

USD/GBP
(-0.05%) $0.785

USD/RUB
(0.15%) $90.40

Realtime updates for Bausch Health Companies [BHC]

Exchange: NYSE Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Last Updated31 May 2024 @ 16:00

25% discount on Stockinvest.us - Use code: Podcast

4.29% $ 6.56

Live Chart Being Loaded With Signals

Commentary (31 May 2024 @ 16:00):

Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology...

Stats
Today's Volume	2.27M
Average Volume	3.12M
Market Cap	2.41B
EPS	$0 ( 2024-05-02 )
Next earnings date	( $0.890 ) 2024-08-01
Last Dividend	$1.000 ( 2010-11-10 )
Next Dividend	$0 ( N/A )
P/E	-5.29
ATR14	$0.0110 (0.17%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-17	Mulligan Richard	Buy	0
2024-05-17	Garcia Christian A	Buy	35 360	Common Shares, No Par Value
2024-05-17	Lee Frank D.	Buy	35 360	Common Shares, No Par Value
2024-05-14	Lee Frank D.	Buy	0
2024-05-17	Wechsler Amy B	Buy	35 360	Common Shares, No Par Value

INSIDER POWER
73.24
Last 97 transactions
Buy: 2 406 981 \| Sell: 334 129

Volume Correlation

Long: 0.36 (neutral)

Short: 0.11 (neutral)

Signal:(70.456) Neutral

Bausch Health Companies Correlation

10 Most Positive Correlations
OBDC	0.898
ET-PE	0.898
RSPU	0.896
OBK	0.893
NEE-PR	0.892
MTB-PH	0.89
PHIN	0.89
BN	0.889
MOH	0.883
INAQ	0.875

10 Most Negative Correlations
ELIQ	-0.927
VSTS	-0.901
MKFG-WT	-0.896
YSG	-0.887
BITE	-0.875
DAC	-0.852
SHPW	-0.849
PHG	-0.848
KDP	-0.844
RC-PC	-0.838

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Bausch Health Companies Correlation - Currency/Commodity

0.23
( neutral )

0.01
( neutral )

0.00
( neutral )

0.00
( neutral )

0.06
( neutral )

-0.14
( neutral )

Bausch Health Companies Financials

Annual	2023
Revenue:	$8.76B
Gross Profit:	$6.20B (70.78 %)
EPS:	$-1.620

FY	2023
Revenue:	$8.76B
Gross Profit:	$6.20B (70.78 %)
EPS:	$-1.620

FY	2022
Revenue:	$8.12B
Gross Profit:	$5.76B (70.90 %)
EPS:	$-0.590

FY	2021
Revenue:	$8.43B
Gross Profit:	$6.04B (71.61 %)
EPS:	$-2.67

Financial Reports:

No articles found.

Bausch Health Companies Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Bausch Health Companies Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 4.01 - low (33.35%) | Divividend Growth Potential Score: 0.787 - No dividend growth expected in the near future

Information

First Dividend	$0.500	2005-11-28
Last Dividend	$1.000	2010-11-10
Next Dividend	$0	N/A
Payout Date	2010-12-22
Next Payout Date	N/A
# dividends	22	--
Total Paid Out	$6.43	--
Avg. Dividend % Per Year	0.00%	--
Score	2.44	--
Div. Sustainability Score	4.01
Div.Growth Potential Score	0.787
Div. Directional Score	2.40	--

Next Divdend (Est)
(2024-06-07)

$0 Estimate 0.00 %

Dividend Stability

0.05 Very Bad

Dividend Score

2.44

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
2005	$0.500	3.07%
2006	$0.500	2.01%
2007	$2.00	9.47%
2008	$1.500	11.20%
2009	$0.645	6.68%
2010	$1.280	8.72%
2011	$0	0.00%
2012	$0	0.00%
2013	$0	0.00%
2014	$0	0.00%
2015	$0	0.00%
2016	$0	0.00%
2017	$0	0.00%
2018	$0	0.00%
2019	$0	0.00%
2020	$0	0.00%
2021	$0	0.00%
2022	$0	0.00%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NYSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
LOMA	Dividend King	2023-06-30	Quarterly	2	5.23%	8.53
ACP	Dividend Royal	2024-05-22	Monthly	14	11.88%	8.50
PVL	Dividend Royal	2023-11-15	Monthly	14	9.37%	8.50
ARR	Dividend Royal	2024-05-14	Monthly	15	11.08%	8.50
ACV	Dividend Royal	2024-06-13	Monthly	10	10.19%	8.50
AVK	Dividend Royal	2024-05-14	Monthly	22	9.54%	8.31
AFG	Dividend Royal	2024-04-12	Bi-Monthly	39	9.39%	8.06
JPT	Dividend King	2023-11-02	Monthly	8	4.19%	8.05
VCIF	Dividend Royal	2023-08-18	Monthly	6	8.05%	8.02
EDI	Dividend Royal	2023-12-07	Monthly	13	8.85%	7.94

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.00231	1.500	-0.0463	-0.0694	[0 - 0.5]
returnOnAssetsTTM	-0.000770	1.200	-0.0257	-0.0308	[0 - 0.3]
returnOnEquityTTM	0.0198	1.500	-0.892	-1.337	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.225	0.800	8.88	7.10	[1 - 3]
quickRatioTTM	0.636	0.800	-0.963	-0.770	[0.8 - 2.5]
cashRatioTTM	0.171	1.500	-0.159	-0.238	[0.2 - 2]
debtRatioTTM	0.820	-1.500	10.00	-10.00	[0 - 0.6]
interestCoverageTTM	-0.844	1.000	-1.424	-1.424	[3 - 30]
operatingCashFlowPerShareTTM	3.13	2.00	8.96	10.00	[0 - 30]
freeCashFlowPerShareTTM	2.28	2.00	8.86	10.00	[0 - 20]
debtEquityRatioTTM	-19.80	-1.500	-10.00	10.00	[0 - 2.5]
grossProfitMarginTTM	0.959	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	0.121	1.000	9.59	9.59	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.0520	1.000	-0.822	-0.822	[0.2 - 2]
assetTurnoverTTM	0.333	0.800	-1.112	-0.890	[0.5 - 2]
Total Score				4.01

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-116.16	1.000	-10.00	0	[1 - 100]
returnOnEquityTTM	0.0198	2.50	-0.573	-1.337	[0.1 - 1.5]
freeCashFlowPerShareTTM	2.28	2.00	9.24	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	3.13	2.00	8.96	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-184.91	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.128	1.000	9.30	0	[0.1 - 0.5]
Total Score				0.787

Bausch Health Companies Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Bausch Health Companies

Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and consumer, surgical, and ophthalmic pharmaceuticals products. The Salix segment provides gastroenterology products in the United States. The International Rx segment offers Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Ortho Dermatologics segment provides dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment offers pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Investing in the stock market involves risk and the value of your investment can fluctuate. The stock market can be affected by a variety of factors, including economic conditions, company performance, and global events. There is no guarantee of profit and you could lose money. Please consider your financial situation, investment goals, and level of risk tolerance before making any investment decisions. Consult with a financial advisor for personalized advice.

Total Execution Time: 3.1947641372681 seconds
Number of API calls: 2
Number of DB calls: 8